SC 13D

Company

ROCKET PHARMACEUTICALS, INC.

Filed

January 16, 2018

Accession Number

0001193125-18-011187

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →